HomeBAFNAPH • NSE
add
Bafna Pharmaceuticals Ltd
Previous close
₹146.75
Day range
₹149.65 - ₹149.68
Year range
₹69.00 - ₹202.06
Market cap
3.44B INR
Avg Volume
5.18K
P/E ratio
40.39
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 354.68M | -12.04% |
Operating expense | 95.97M | -7.28% |
Net income | 31.25M | 19.39% |
Net profit margin | 8.81 | 35.75% |
Earnings per share | — | — |
EBITDA | 42.31M | 13.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.54M | -80.65% |
Total assets | 1.61B | 19.77% |
Total liabilities | 694.55M | 35.10% |
Total equity | 912.28M | — |
Shares outstanding | 23.67M | — |
Price to book | 3.81 | — |
Return on assets | — | — |
Return on capital | 5.94% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 31.25M | 19.39% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1981
Website
Employees
406
